PCI approved, UGC recognised
Carrying forth the Apeejay Stya legacy of over 45 years of excellence in education
School of Pharmaceutical Sciences
Unique Propositions of School
• Industry experienced faculty with avant - garde research
• Cutting edge research labs with sophisticated and latest instruments
• Industry centric curriculum
• Research opportunities at all levels
• Hands on training and placement in varied pharma sectors
• Strong Industry-Academia Linkages
• International Library with free access to indexed journals
CORPORATE CONNECT
• Collaboration with Industry stalwarts with respect to joint research projects, internships, advice on industry aligned curriculum, design and delivery & guest lectures.
• Renowned researchers, academicians and industrialist who guide students from time to time include: Dr. Vipin Dhall, Vice - President, Piramal Healthcare; Dr. Arvind Bansal, Professor, Pharmaceutics, NIPER; Dr. Ravi Kochchar, Sr. Scientist, Ranbaxy Labs; Mr. Satish Sharma, Director, Training and Consultant - Business Advantage; Dr. Mita Nandi, A renowned Clinical Trial Specialist, Fortis Hospital, Noida; Mr. Arvind Madan, GM, Modi - MundiPharma Ltd; Ms. Navita, leading entrepreneur, a Pharmacovigilant specialist and many others.
• Internship Projects and Placements : Students have been placed for industry projects at various R&D centres like Piramal Healthcare, Wockhardt Ltd, Finoso Lab, Dabur India and many others.
Experience the International Edge...
· Established on the academic pattern of the lvy League universities of the USA
· Trans-disciplinary and Liberal Arts approach
· Strong industry linkages to facilitate training & placement
· Truly global campus with students from over 15 countries
Awards & Accolades
· Best Innovation by Private University at World Education Summit 2012
· No.1 in Innovative Teaching Techniques & No. 3 in Most Reputed Faculty as per TOI B-School Ratings 2013 (North Region)
· Mr. Aditya Berlia, Co-Founder & Pro-Chancellor, Apeejay Stya University, received the 'Outstanding Educational Entrepreneur' award at the World Education Congress Global Awards 2013.
· ASU has been conferred the 'CSR Excellence in Education Award 2013' by Competition Success Review (CSR) magazine in recognition of exceptional contribution made by institutions in their respective areas like education, scientific research, etc.
· E-Gov. Campus of Gurgaon District, Haryana (India) by the Ministry of Communications & Information Technology, in collaboration with the United Nations
· Best Engineering Institute in North India at National Education Awards 2013 by ET Now
Programmes Offered
MASTERS
• M. Pharm. in Pharmaceutics
• M. Pharm. in Drug Regulatory Affairs
Duration:2 yrs
• M. Pharm. + MBA
Duration:3 yrs (Dual Degree Programme)
BACHELORS
• B. Pharm.
Duration: 4 yrs.
PG DIPLOMA
- Drug Regulatory Affairs: Legal requirements to bring pharmaceutical products to domestic as well as international markets and covering dossier preparation in CTD format, ACTD submissions and e-CTD submissions.
- Intellectual Property Rights: Intellectual Property Rights system (Indian and International) focusing on patent drafting, claim writing, Para 4/5B/B1/B2, filling, Patent infringement and issues.
- Pharmacovigilance: Skills to collect and report adverse, serious adverse events, safety data and risk managementfor effective drug safety programme.
- Pharma Sales Management: Skill development of the participants to cross the threshold of their present assignment and take up higher responsibilities.
- Pharmacoeconomics: Healthcare interventions, strategies to be incorporated for pharmacotherapy, economic evaluation in clinical trials and hence to understand effective health care management & managing innovations at affordable cost for the society.
DOCTORAL
• Ph.D in Pharmaceutical Sciences
Online courses offered by SPS: Teaching and learnings shared by Stalwarts of respective fields.
|
For any further details feel free to call at +91-8448300783 |
Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.
